|29.64||-1.68 / -5.36%|
Data as of 4:00pm ET
|29.64||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 40.00, with a high estimate of 52.00 and a low estimate of 38.00. The median estimate represents a +34.95% increase from the last price of 29.64.
The current consensus among 6 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.